Localized and Reversible TGFbeta Signalling Switches Breast Cancer Cells from Cohesive to Single Cell Motility

Overview

Journal Nat Cell Biol

Specialty Cell Biology

Date 2009 Oct 20

PMID 19838175

Citations 322

Authors

Silvia Giampieri

Cerys Manning

Steven Hooper

Louise Jones

Caroline S Hill

Erik Sahai

Affiliations

Soon will be listed here.

Abstract

Here we use intravital imaging to demonstrate a reversible transition to a motile state as breast cancer cells spread. Imaging primary tumours revealed heterogeneity in cell morphology and motility. Two distinct modes of motility were observed: collective and single-celled. By monitoring the localization of Smad2 and the activity of a TGFbeta-dependent reporter gene during breast cancer cell dissemination, we demonstrate that TGFbeta signalling is transiently and locally activated in motile single cells. TGFbeta1 switches cells from cohesive to single cell motility through a transcriptional program involving Smad4, EGFR, Nedd9, M-RIP, FARP and RhoC. Blockade of TGFbeta signalling prevented cells moving singly in vivo but did not inhibit cells moving collectively. Cells restricted to collective invasion were capable of lymphatic invasion but not blood-borne metastasis. Constitutive TGFbeta signalling promoted single cell motility and intravasation but reduced subsequent growth in the lungs. Thus, transient TGFbeta signalling is essential for blood-borne metastasis.

Citing Articles

The Prognostic Significance of NEDD9 Expression in Human Cancers: A Systematic Review, Meta-Analysis, and Omics Exploration.

Yasin J, Odat R, Qtaishat F, Tamimi M, Alsufi M, Younis O Technol Cancer Res Treat. 2024; 23:15330338241297597.

PMID: 39540210 PMC: 11561999. DOI: 10.1177/15330338241297597.

Proteolysis-free amoeboid migration of melanoma cells through crowded environments via bleb-driven worrying.

Driscoll M, Welf E, Weems A, Sapoznik E, Zhou F, Murali V Dev Cell. 2024; 59(18):2414-2428.e8.

PMID: 38870943 PMC: 11421976. DOI: 10.1016/j.devcel.2024.05.024.

Exploring the Immunological Profile in Breast Cancer: Recent Advances in Diagnosis and Prognosis through Circulating Tumor Cells.

Kotsifaki A, Maroulaki S, Armakolas A Int J Mol Sci. 2024; 25(9).

PMID: 38732051 PMC: 11084220. DOI: 10.3390/ijms25094832.

Different Modes of Mechanism of Gamma-Mangostin and Alpha-Mangostin to Inhibit Cell Migration of Triple-Negative Breast Cancer Cells Concerning Downregulation and ROS Generation.

Sarmoko S, Novitasari D, Toriyama M, Fareza M, Choironi N, Itoh H Iran J Pharm Res. 2024; 22(1):e138856.

PMID: 38655233 PMC: 11036650. DOI: 10.5812/ijpr-138856.

Targeting SMAD-Dependent Signaling: Considerations in Epithelial and Mesenchymal Solid Tumors.

Runa F, Ortiz-Soto G, de Barros N, Kelber J Pharmaceuticals (Basel). 2024; 17(3).

PMID: 38543112 PMC: 10975212. DOI: 10.3390/ph17030326.

References

Lesko E, Majka M . The biological role of HGF-MET axis in tumor growth and development of metastasis. Front Biosci. 2007; 13:1271-80. DOI: 10.2741/2760. View

Schmierer B, Hill C . Kinetic analysis of Smad nucleocytoplasmic shuttling reveals a mechanism for transforming growth factor beta-dependent nuclear accumulation of Smads. Mol Cell Biol. 2005; 25(22):9845-58. PMC: 1280270. DOI: 10.1128/MCB.25.22.9845-9858.2005. View

Gilles C, Polette M, Mestdagt M, Nawrocki-Raby B, Ruggeri P, Birembaut P . Transactivation of vimentin by beta-catenin in human breast cancer cells. Cancer Res. 2003; 63(10):2658-64. View

Siegel P, Massague J . Cytostatic and apoptotic actions of TGF-beta in homeostasis and cancer. Nat Rev Cancer. 2003; 3(11):807-21. DOI: 10.1038/nrc1208. View

Wyckoff J, Wang Y, Lin E, Li J, Goswami S, Stanley E . Direct visualization of macrophage-assisted tumor cell intravasation in mammary tumors. Cancer Res. 2007; 67(6):2649-56. DOI: 10.1158/0008-5472.CAN-06-1823. View

Wells A . Tumor invasion: role of growth factor-induced cell motility. Adv Cancer Res. 1999; 78:31-101. DOI: 10.1016/s0065-230x(08)61023-4. View

Xue C, Wyckoff J, Liang F, Sidani M, Violini S, Tsai K . Epidermal growth factor receptor overexpression results in increased tumor cell motility in vivo coordinately with enhanced intravasation and metastasis. Cancer Res. 2006; 66(1):192-7. DOI: 10.1158/0008-5472.CAN-05-1242. View

Philippar U, Roussos E, Oser M, Yamaguchi H, Kim H, Giampieri S . A Mena invasion isoform potentiates EGF-induced carcinoma cell invasion and metastasis. Dev Cell. 2008; 15(6):813-28. PMC: 2637261. DOI: 10.1016/j.devcel.2008.09.003. View

Fox S, Harris A . The epidermal growth factor receptor in breast cancer. J Mammary Gland Biol Neoplasia. 1997; 2(2):131-41. DOI: 10.1023/a:1026399613946. View

10.

Donovan J, Slingerland J . Transforming growth factor-beta and breast cancer: Cell cycle arrest by transforming growth factor-beta and its disruption in cancer. Breast Cancer Res. 2001; 2(2):116-24. PMC: 139433. DOI: 10.1186/bcr43. View

11.

Padua D, Zhang X, Wang Q, Nadal C, Gerald W, Gomis R . TGFbeta primes breast tumors for lung metastasis seeding through angiopoietin-like 4. Cell. 2008; 133(1):66-77. PMC: 2390892. DOI: 10.1016/j.cell.2008.01.046. View

12.

Zavadil J, Bottinger E . TGF-beta and epithelial-to-mesenchymal transitions. Oncogene. 2005; 24(37):5764-74. DOI: 10.1038/sj.onc.1208927. View

13.

Vincent-Salomon A, Thiery J . Host microenvironment in breast cancer development: epithelial-mesenchymal transition in breast cancer development. Breast Cancer Res. 2003; 5(2):101-6. PMC: 154156. DOI: 10.1186/bcr578. View

14.

Nicholson R, Gee J, Harper M . EGFR and cancer prognosis. Eur J Cancer. 2001; 37 Suppl 4:S9-15. DOI: 10.1016/s0959-8049(01)00231-3. View

15.

Levy L, Hill C . Alterations in components of the TGF-beta superfamily signaling pathways in human cancer. Cytokine Growth Factor Rev. 2005; 17(1-2):41-58. DOI: 10.1016/j.cytogfr.2005.09.009. View

16.

Wyckoff J, Jones J, Condeelis J, Segall J . A critical step in metastasis: in vivo analysis of intravasation at the primary tumor. Cancer Res. 2000; 60(9):2504-11. View

17.

Mi Z, Guo H, Wai P, Gao C, Wei J, Kuo P . Differential osteopontin expression in phenotypically distinct subclones of murine breast cancer cells mediates metastatic behavior. J Biol Chem. 2004; 279(45):46659-67. DOI: 10.1074/jbc.M407952200. View

18.

Kokkinos M, Wafai R, Wong M, Newgreen D, Thompson E, Waltham M . Vimentin and epithelial-mesenchymal transition in human breast cancer--observations in vitro and in vivo. Cells Tissues Organs. 2007; 185(1-3):191-203. DOI: 10.1159/000101320. View

19.

Wang W, Goswami S, Lapidus K, Wells A, Wyckoff J, Sahai E . Identification and testing of a gene expression signature of invasive carcinoma cells within primary mammary tumors. Cancer Res. 2004; 64(23):8585-94. DOI: 10.1158/0008-5472.CAN-04-1136. View

20.

Friedl P . Prespecification and plasticity: shifting mechanisms of cell migration. Curr Opin Cell Biol. 2004; 16(1):14-23. DOI: 10.1016/j.ceb.2003.11.001. View